This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Chlorthalidone

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220804

Version

3

Spl Product Data Elements

Chlorthalidone Chlorthalidone CHLORTHALIDONE CHLORTHALIDONE CELLULOSE, MICROCRYSTALLINE FERRIC OXIDE YELLOW SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN STEARIC ACID LIGHT YELLOW ROUND Z25 Chlorthalidone Chlorthalidone CHLORTHALIDONE CHLORTHALIDONE CELLULOSE, MICROCRYSTALLINE SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN STEARIC ACID WHITE ROUND Z;50

Application Number

ANDA207813

Brand Name

Chlorthalidone

Generic Name

Chlorthalidone

Product Ndc

70771-1370

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1369-1 Chlorthalidone tablets USP ,25 mg Rx only 100 tablets NDC 70771-1370-1 Chlorthalidone tablets USP, 50 mg Rx only 100 tablets Chlorthalidone tablets, USP Chlorthalidone tablets, USP

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.